Hyperparathyroidism in X-linked hypophosphatemia
-
- STATUS
- Not Recruiting
Summary
The purpose of this study is to identify patients with XLH from the electronic health record (EHR) in INPC in order to assess the occurrence of side effects of treatment with calcitriol and phosphate including secondary hyperparathyroidism, tertiary hyperparathyroidism, parathyroidectomy and the outcomes of parathyroidectomy, and nephrocalcinosis.
Description
The purpose of this study is to identify patients with XLH from the electronic health record (EHR) in INPC in order to assess the occurrence of side effects of treatment with calcitriol and phosphate including secondary hyperparathyroidism, tertiary hyperparathyroidism, parathyroidectomy and the outcomes of parathyroidectomy, and nephrocalcinosis.
Details
| Condition | X-linked hypophosphatemia,hyperparathyroidism |
|---|---|
| Age | 100years or below |
| Clinical Study Identifier | TX8583 |
| Last Modified on | 19 February 2024 |
Similar trials to consider
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.